Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2012

Open Access 01-12-2012 | Research

Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB

Authors: Hong Wang, Xin Sun, Feng Gao, Biao Zhong, Yong-hua Zhang, Zhijun Sun

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2012

Login to get access

Abstract

Objective

This study aims to investigate the in vitro effects of Ulinastatin (UTI) and Taxotere (TXT) on cell proliferation; cell apoptosis; xenografted tumor growth; and expression of insulin-like growth factor receptor 1 (IGF-1R), platelet-derived growth factor A (PDGFA), nerve growth factor (NGF), c-Jun N-terminal kinase 2 (JNk-2), and NF-κB in a human primary breast cancer cells and breast cancer cell line MDA-MB-231.

Methods

The cell lines cultured were divided into four groups: 1) control group, 2) UTI group, 3) TXT group, and 4) UTI+TXT group. The method of MTT essay, flow cytometry, and RT-PCR were used to detect cell proliferation, cell apoptosis, and expression of IGF-1R, PDGFA, NGF, NF-κB, JNk-2, respectively. The growth of xenografted tumor in nude mice was used to calculate the anti-tumor rate. Immunohistochemistry staining (SP) was used to detect the expression of IGF-1R, PDGFA, NGF, ki-67, caspase-3, JNk-2, and NF-κB.

Results

Proliferation of human breast cancer cells and MDA-MB-231 cell lines, and growth rate of xenografted tumor decreased in order of UTI+TXT > TXT > UTI > control, apoptosis increased in the order control < UTI < TXT < UTI+TXT. The gene expression and protein expression of IGF-1R, PDGFA, NGF, NF-κB and JNk-2 in breast cancer cells was inhibited by UTI and TXT.

Conclusions

UTI 1) inhibits the proliferation of human breast cancer cells and the growth of xenografted tumors, 2) induces cancer cell apoptosis, and 3) enhances the anti-tumor effect of TXT. This mechanism might be related to decreasing signal transduction of JNk-2 and NF-κB, and then expression of IGF-1R, PDGFA, NGF.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mohinta S, Mohinta H, Chaurasia P, Watabe K: Wnt pathway and breast cancer. Front Biosci. 2007, 12: 4020-4033. 10.2741/2368.CrossRefPubMed Mohinta S, Mohinta H, Chaurasia P, Watabe K: Wnt pathway and breast cancer. Front Biosci. 2007, 12: 4020-4033. 10.2741/2368.CrossRefPubMed
2.
go back to reference Takano H, Inoue K, Shimada A, Sato H, Yanagisawa R, Yoshikawa T: Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice. Lab Invest. 2009, 89: 833-839. 10.1038/labinvest.2009.35.CrossRefPubMed Takano H, Inoue K, Shimada A, Sato H, Yanagisawa R, Yoshikawa T: Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice. Lab Invest. 2009, 89: 833-839. 10.1038/labinvest.2009.35.CrossRefPubMed
3.
go back to reference Inoue K, Takano H: Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders. Expert Opin Investig Drugs. 2010, 19: 513-520. 10.1517/13543781003649533.CrossRefPubMed Inoue K, Takano H: Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders. Expert Opin Investig Drugs. 2010, 19: 513-520. 10.1517/13543781003649533.CrossRefPubMed
4.
go back to reference Sun ZJ, Yu T, Chen JS, Sun X, Gao F: Effects of Ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXCR4 and MMP-9 in cancers. J Int Med Res. 2010, 38: 967-976.CrossRefPubMed Sun ZJ, Yu T, Chen JS, Sun X, Gao F: Effects of Ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXCR4 and MMP-9 in cancers. J Int Med Res. 2010, 38: 967-976.CrossRefPubMed
5.
go back to reference Chen JS, Sun Z, Yu T: Effect of Ulinastatin and Taxotare on proliferation and inhibition of breast carcinoma and expression in MMP-9. J Chinese Biological Products. 2009, 22: 865-868. Chen JS, Sun Z, Yu T: Effect of Ulinastatin and Taxotare on proliferation and inhibition of breast carcinoma and expression in MMP-9. J Chinese Biological Products. 2009, 22: 865-868.
6.
go back to reference van der Kuip H, Mürdter TE, Sonnenberg M, van der Kuip Heiko, Mürdter Thomas, Sonnenberg Maike, McClellan M, Gutzeit S, Gerteis A, Simon W, Fritz P, Aulitzky W: Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer. 2006, 6: 86-10.1186/1471-2407-6-86.PubMedCentralCrossRefPubMed van der Kuip H, Mürdter TE, Sonnenberg M, van der Kuip Heiko, Mürdter Thomas, Sonnenberg Maike, McClellan M, Gutzeit S, Gerteis A, Simon W, Fritz P, Aulitzky W: Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer. 2006, 6: 86-10.1186/1471-2407-6-86.PubMedCentralCrossRefPubMed
7.
go back to reference Bayet-Robert M, Morvan D, Chollet P, Barthomeuf C: Pharmacometabolomics of docetaxel-treated human MCF-7 breast cancer cells provides evidence of varying cellular responses at high and low doses. Breast Cancer Res Treat. 2010, 120: 613-626. 10.1007/s10549-009-0430-1.CrossRefPubMed Bayet-Robert M, Morvan D, Chollet P, Barthomeuf C: Pharmacometabolomics of docetaxel-treated human MCF-7 breast cancer cells provides evidence of varying cellular responses at high and low doses. Breast Cancer Res Treat. 2010, 120: 613-626. 10.1007/s10549-009-0430-1.CrossRefPubMed
8.
go back to reference Koechli OR, Avner BP, Sevin BU, Avner B, Perras J, Robinson D, Averette H: Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results. J Surg Oncol. 2003, 54: 119-125.CrossRef Koechli OR, Avner BP, Sevin BU, Avner B, Perras J, Robinson D, Averette H: Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results. J Surg Oncol. 2003, 54: 119-125.CrossRef
9.
go back to reference Lyzogubov V, Khozhaenko Y, Usenko V: Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer. Exp Oncol. 2005, 27: 141-144.PubMed Lyzogubov V, Khozhaenko Y, Usenko V: Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer. Exp Oncol. 2005, 27: 141-144.PubMed
10.
go back to reference Ahlin C, Fernö M, Amini RM, Tolockiene E, Blomqvist C, Bergh J, Fjällskog ML: Ki-67 and cyclin A--prognostic factors in breast cancer. Time to introduce proliferation markers in clinical routine. Lakartidningen. 2010, 107: 672-675.PubMed Ahlin C, Fernö M, Amini RM, Tolockiene E, Blomqvist C, Bergh J, Fjällskog ML: Ki-67 and cyclin A--prognostic factors in breast cancer. Time to introduce proliferation markers in clinical routine. Lakartidningen. 2010, 107: 672-675.PubMed
11.
go back to reference Wesierska-Gadek J, Hackl S, Zulehner N, Maurer M, Komina O: Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors. J Cell Biochem. 2011, 112: 273-288. 10.1002/jcb.22918.CrossRefPubMed Wesierska-Gadek J, Hackl S, Zulehner N, Maurer M, Komina O: Reconstitution of human MCF-7 breast cancer cells with caspase-3 does not sensitize them to action of CDK inhibitors. J Cell Biochem. 2011, 112: 273-288. 10.1002/jcb.22918.CrossRefPubMed
12.
go back to reference Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL: Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene. 2004, 23: 596-604. 10.1038/sj.onc.1207147.CrossRefPubMed Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL: Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene. 2004, 23: 596-604. 10.1038/sj.onc.1207147.CrossRefPubMed
13.
go back to reference Sachdev D, Zhang X, Matise I, Matise I, Gaillard-Kelly M, Yee D: The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene. 2010, 29: 251-262. 10.1038/onc.2009.316.PubMedCentralCrossRefPubMed Sachdev D, Zhang X, Matise I, Matise I, Gaillard-Kelly M, Yee D: The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene. 2010, 29: 251-262. 10.1038/onc.2009.316.PubMedCentralCrossRefPubMed
14.
go back to reference Zeng X, Sachdev D, Zhang H, Gaillard-Kelly M, Yee D: Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo. Clin Cancer Res. 2009, 15: 2840-2849. 10.1158/1078-0432.CCR-08-1401.PubMedCentralCrossRefPubMed Zeng X, Sachdev D, Zhang H, Gaillard-Kelly M, Yee D: Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo. Clin Cancer Res. 2009, 15: 2840-2849. 10.1158/1078-0432.CCR-08-1401.PubMedCentralCrossRefPubMed
15.
go back to reference Yanochko GM, Eckhart W: Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells. Breast Cancer Res. 2006, 8 (2): R18-10.1186/bcr1392.PubMedCentralCrossRefPubMed Yanochko GM, Eckhart W: Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells. Breast Cancer Res. 2006, 8 (2): R18-10.1186/bcr1392.PubMedCentralCrossRefPubMed
16.
go back to reference Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F: Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression. Breast Cancer Res. 2005, 7: 788-795. 10.1186/bcr1304.CrossRef Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F: Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression. Breast Cancer Res. 2005, 7: 788-795. 10.1186/bcr1304.CrossRef
17.
go back to reference Pasanisi P, Venturelli E, Morelli D, Morelli D Fontana L, Secreto G, Berrino F: Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1719-1722. 10.1158/1055-9965.EPI-07-0654.CrossRefPubMed Pasanisi P, Venturelli E, Morelli D, Morelli D Fontana L, Secreto G, Berrino F: Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2008, 17: 1719-1722. 10.1158/1055-9965.EPI-07-0654.CrossRefPubMed
18.
go back to reference Lev DC, Kim SJ, Onn A, Stone V, Nam DH, Yazici S, Fidler IJ, Price JE: Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. Clin Cancer Res. 2005, 11: 306-314.PubMed Lev DC, Kim SJ, Onn A, Stone V, Nam DH, Yazici S, Fidler IJ, Price JE: Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. Clin Cancer Res. 2005, 11: 306-314.PubMed
19.
go back to reference Kang DW, Min do S: Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cell. Cancer Lett. 2010, 294: 125-133. 10.1016/j.canlet.2010.01.031.CrossRefPubMed Kang DW, Min do S: Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cell. Cancer Lett. 2010, 294: 125-133. 10.1016/j.canlet.2010.01.031.CrossRefPubMed
20.
go back to reference Chiarenza A, Lazarovici P, Lempereur L, Cantarella G, Bianchi A, Bernardini R: Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. Cancer Res. 2001, 61: 3002-3008.PubMed Chiarenza A, Lazarovici P, Lempereur L, Cantarella G, Bianchi A, Bernardini R: Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. Cancer Res. 2001, 61: 3002-3008.PubMed
21.
go back to reference Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X, Hondermarck H: Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 2008, 68: 346-351. 10.1158/0008-5472.CAN-07-1183.CrossRefPubMed Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X, Hondermarck H: Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 2008, 68: 346-351. 10.1158/0008-5472.CAN-07-1183.CrossRefPubMed
22.
go back to reference Dollé L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H: Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene. 2003, 22: 5592-5601. 10.1038/sj.onc.1206805.CrossRefPubMed Dollé L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H: Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene. 2003, 22: 5592-5601. 10.1038/sj.onc.1206805.CrossRefPubMed
23.
go back to reference Descamps S, Pawlowski V, Révillion F, Hornez L, Hebbar M, Boilly B, Hondermarck H, Peyrat JP: Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res. 2001, 61: 4337-4340.PubMed Descamps S, Pawlowski V, Révillion F, Hornez L, Hebbar M, Boilly B, Hondermarck H, Peyrat JP: Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res. 2001, 61: 4337-4340.PubMed
24.
go back to reference Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H: Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem. 2001, 276: 17864-17870. 10.1074/jbc.M010499200.CrossRefPubMed Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H: Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem. 2001, 276: 17864-17870. 10.1074/jbc.M010499200.CrossRefPubMed
Metadata
Title
Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB
Authors
Hong Wang
Xin Sun
Feng Gao
Biao Zhong
Yong-hua Zhang
Zhijun Sun
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2012
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-31-2

Other articles of this Issue 1/2012

Journal of Experimental & Clinical Cancer Research 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine